ATE254173T1 - P75 tnf-rezeptor-promotoren - Google Patents

P75 tnf-rezeptor-promotoren

Info

Publication number: ATE254173T1
Authority: AT; Austria
Prior art keywords: promotors; tnf receptor; sequence; upstream; preparation
Prior art date: 1994-05-11

Application number

AT95919786T

Other languages

English (en)

Inventor

David Wallach

Peter Kuhnert

Gotz Ehrhardt

Oliver Kemper

Original Assignee

Yeda Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-11

Filing date

1995-05-11

Publication date

2003-11-15

1995-05-11 Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev

2003-11-15 Application granted granted Critical

2003-11-15 Publication of ATE254173T1 publication Critical patent/ATE254173T1/de

Links

230000002401 inhibitory effect Effects 0.000 abstract 1
230000035897 transcription Effects 0.000 abstract 1
238000013518 transcription Methods 0.000 abstract 1
238000011144 upstream manufacturing Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Veterinary Medicine (AREA)
General Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Wood Science & Technology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Physics & Mathematics (AREA)
Rheumatology (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

AT95919786T 1994-05-11 1995-05-11 P75 tnf-rezeptor-promotoren ATE254173T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IL10963394A IL109633A (en)	1994-05-11	1994-05-11	Tnf receptor promoter
PCT/US1995/005853 WO1995031206A1 (en)	1994-05-11	1995-05-11	P75 tnf receptor promoters

Publications (1)

Publication Number	Publication Date
ATE254173T1 true ATE254173T1 (de)	2003-11-15

Family

ID=11066126

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95919786T ATE254173T1 (de)	1994-05-11	1995-05-11	P75 tnf-rezeptor-promotoren

Country Status (13)

Country	Link
EP (1)	EP0759759B1 (de)
JP (1)	JP3663211B2 (de)
AT (1)	ATE254173T1 (de)
AU (1)	AU699280B2 (de)
CA (1)	CA2189984C (de)
CY (1)	CY2524B1 (de)
DE (1)	DE69532115T2 (de)
DK (1)	DK0759759T3 (de)
ES (1)	ES2206505T3 (de)
IL (1)	IL109633A (de)
PT (1)	PT759759E (de)
WO (1)	WO1995031206A1 (de)
ZA (1)	ZA953841B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL114615A0 (en)	1995-07-16	1995-11-27	Yeda Res & Dev	Modulators of the function of fas receptors and other proteins
US6287558B1 (en)	1997-08-01	2001-09-11	Biohybrio Technologies Llc	Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
IL178921A0 (en) *	1998-12-24	2007-03-08	Yeda Res & Dev	Caspase-8 interacting proteins
WO2006115509A2 (en)	2004-06-24	2006-11-02	Novartis Vaccines And Diagnostics Inc.	Small molecule immunopotentiators and assays for their detection
CA2851996C (en)	2011-11-01	2020-01-07	Resverlogix Corp.	Pharmaceutical compositions for substituted quinazolinones
US10125168B2 (en)	2012-09-20	2018-11-13	Toagosei Co. Ltd.	Synthetic peptide for adjusting balance between presence of type 1 TNF receptor and type 2 TNF receptor and use thereof

1994
- 1994-05-11 IL IL10963394A patent/IL109633A/xx not_active IP Right Cessation
1995
- 1995-05-11 AU AU25468/95A patent/AU699280B2/en not_active Expired
- 1995-05-11 EP EP95919786A patent/EP0759759B1/de not_active Expired - Lifetime
- 1995-05-11 JP JP52974795A patent/JP3663211B2/ja not_active Expired - Lifetime
- 1995-05-11 WO PCT/US1995/005853 patent/WO1995031206A1/en not_active Ceased
- 1995-05-11 ZA ZA953841A patent/ZA953841B/xx unknown
- 1995-05-11 ES ES95919786T patent/ES2206505T3/es not_active Expired - Lifetime
- 1995-05-11 DK DK95919786T patent/DK0759759T3/da active
- 1995-05-11 CA CA002189984A patent/CA2189984C/en not_active Expired - Lifetime
- 1995-05-11 AT AT95919786T patent/ATE254173T1/de not_active IP Right Cessation
- 1995-05-11 PT PT95919786T patent/PT759759E/pt unknown
- 1995-05-11 DE DE69532115T patent/DE69532115T2/de not_active Expired - Lifetime
2005
- 2005-04-18 CY CY0500024A patent/CY2524B1/xx unknown

Also Published As

Publication number	Publication date
WO1995031206A1 (en)	1995-11-23
CA2189984C (en)	2008-03-25
EP0759759A4 (de)	1997-11-26
DE69532115D1 (de)	2003-12-18
DE69532115T2 (de)	2004-08-26
DK0759759T3 (da)	2004-02-02
IL109633A0 (en)	1994-08-26
ZA953841B (en)	1996-01-17
AU699280B2 (en)	1998-11-26
CA2189984A1 (en)	1995-11-23
IL109633A (en)	2005-05-17
CY2524B1 (en)	2006-02-08
ES2206505T3 (es)	2004-05-16
EP0759759B1 (de)	2003-11-12
EP0759759A1 (de)	1997-03-05
PT759759E (pt)	2004-01-30
JPH10500304A (ja)	1998-01-13
JP3663211B2 (ja)	2005-06-22
AU2546895A (en)	1995-12-05

Similar Documents

Publication	Publication Date	Title
WO1992013950A3 (fr)	1993-02-04	SEQUENCES NUCLEOTIDIQUES CODANT POUR DES REGIONS VARIABLES DE CHAINES β DES RECEPTEURS DES LYMPHOCYTES T HUMAINS, SEGMENTS PEPTIDIQUES CORRESPONDANTS ET LES APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES
PL331091A1 (en)	1999-06-21	Therapeutic multispecific compounds encompassing antibodies against the fcalpha receptor
NO951138L (no)	1995-03-24	Mikropartikkelpreparater fremstilt fra biologisk nedbrytbare blandingspolymerer
TR199501635A1 (tr)	1996-10-21	Solunum yolu ile alinan terapötik preparatlar.
IL125124A0 (en)	1999-01-26	Dimeric forms of the protein fapalpha and uses thereof
ITRM920412A0 (it)	1992-05-29	Eteroprostanoidi, procedimento per la loro preparazione e loro impiegoterapeutico.
EP0583050A3 (de)	1994-10-05	Rekombinanter, stimulierender Faktor für den "neu"-Rezeptor.
DE69328025D1 (de)	2000-04-13	Dorsalgewebe beeinflussender faktor und zusammensetzungen
DE69532115D1 (de)	2003-12-18	P75 tnf-rezeptor-promotoren
WO1997012963A3 (en)	1997-06-12	A paf-acetylhydrolase and use in therapy
ZA9610278B (en)	1998-06-08	Pyridylcarbamates, processes and intermediates for their preparation, and their use.
ITMI913465A0 (it)	1991-12-23	Procedimento per la depurazione dell'1.1.1-trifluoro-2-fuoroetano
ZA966489B (en)	1997-02-26	New protein human MP52 Arg.
ZA969645B (en)	1998-05-18	Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides.
ZA200202823B (en)	2003-09-23	Self-cleaving RNA sequences and their use for the control of protein synthesis.
ITMI942671A0 (it)	1994-12-29	Catalizzatori per la (co) polinerizzazione dell'etilene
GB2325466A (en)	1998-11-25	Nucleotide sequence from goat liver
IT1252659B (it)	1995-06-20	Procedimento per la depurazione dell'1,1,1-trifluoro-2-fluoroetano e dell'1,1,1-trifluoro-2,2-dicloroetano
FR2715821B1 (fr)	1997-09-05	Dispositif d'aide à la rééducation fonctionnelle, notamment du rachis.
RU95122486A (ru)	1998-01-27	Средство для лечения тикозных гиперкинезов
FR2717073B1 (fr)	1996-08-23	Bac à shampoing pour malades allongés, notamment pour grabataires.
FR2703251B3 (fr)	1995-08-04	Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine .
ITTO920656A1 (it)	1994-01-31	Sedia per operativita' chirurgica.
高小康 et al.	1994	The Study of Classical Literature and Contemporary Culture
GB9006500D0 (en)	1990-05-23	Therapeutic agents,and intermediates for the synthesis thereof

Legal Events

Date

Code

Title

Description

2004-07-15

UEP

Publication of translation of european patent specification

Ref document number: 0759759

Country of ref document: EP

2010-02-15

REN

Ceased due to non-payment of the annual fee